Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 nov. 2025 05h15 HE | Source: Research and Markets

Gaucher Disease Global Clinical Trials Market Review 2025: Trial Enrollment, Geographic Hotspots, and Prominent Drugs in Development

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Gaucher Disease - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The provides an overview of...
11 nov. 2025 16h01 HE | Source: Metagenomi, Inc.

Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development

MGX-001 demonstrated curative FVIII activity in non-human primates Pre-IND regulatory meeting expected in Q4 2025 with investigational new drug (IND) and clinical trial application (CTA) submissions...
03 nov. 2025 06h49 HE | Source: Research and Markets

Preclinical CRO Trends and Forecast Report 2025: An $11.3 Billion Market by 2033, Driven by R&D Outsourcing, Rising Chronic Disease Burden, and AI-Enabled Drug Discovery Partnerships

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market Size, Share, Trends, and Forecast by Service, End Use, and Region, 2025-2033" has been added to ResearchAndMarkets.com's...
03 nov. 2025 06h40 HE | Source: Research and Markets

ADME Toxicology Testing Market Technologies, Methods, Applications and Competition Analysis 2021-2030 - High-Throughput Screening and AI-Enhanced Methods are Improving Drug Discovery Efficiency

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Global ADME Toxicology Testing Market - Technologies, Methods and Applications" has been added to ResearchAndMarkets.com's offering. The global ADME...
03 nov. 2025 06h10 HE | Source: Research and Markets

CD40 Targeted Therapies Opportunity Insights Report 2026-2027: Market is Emerging with Over 35 Therapies in Trials and is Driven by Technological Innovations and Global Collaborations

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches, Proprietary Technology Platforms & Market Opportunity Insight 2026" report has...
03 nov. 2025 06h06 HE | Source: Research and Markets

Lung Cancer Antibody Drug Conjugates Research 2025: A $2 Billion Opportunity in 2030, Led by AstraZeneca, Daiichi Sankyo, Pfizer, and BMS Advancing Targeted Therapies Against HER2, TROP-2, and B7-H3

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Lung Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price & Clinical Trials Insight 2030" report has been added to ...
03 nov. 2025 05h54 HE | Source: Research and Markets

Breast Cancer Antibody Drug Conjugates Market Research 2025-2030: $7 Billion Market Led by Daiichi Sankyo and AstraZeneca, with Rising Competition from Roche, Pfizer/Seagen, ADC Therapeutics

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030" report has been added...
29 oct. 2025 08h34 HE | Source: Research and Markets

Mice Model Technologies Research Report 202: Market Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033

Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The "Mice Model Technologies Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
20 oct. 2025 09h54 HE | Source: Research and Markets

DNA Cancer Vaccine Clinical Trials & Market Opportunity Outlook 2026 | First Commercial Approval of DNA Cancer Vaccine Anticipated by 2030

Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "DNA Cancer Vaccine Clinical Trials, Development Technology Platforms & Market Opportunity Outlook 2026" report has been added to ...
20 oct. 2025 06h46 HE | Source: Research and Markets

Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025 | Top 25 Dealmakers, Emerging Collaboration Trends, and 1,670+ Preclinical-Stage Pharma and Biotech Deals Worldwide

Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025" report has been added to ResearchAndMarkets.com's offering.The...

Page suivante